InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the complete record of transactions filed by Peacock Jonathan M, 董事. Director active across 2 companies, notably Avantor, Inc.. In total, 7 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €91k. Activity tracked since 1 April 2022. The latest transaction was filed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Peacock Jonathan M is Administrateur. He has 7 filings in total, and across the sampled recent filings, the activity runs from 2016-01-27 to 2025-05-12, with EUR 90844 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution. He is linked to Avantor, Inc. as Director and to Bellerophon Therapeutics, Inc. as President and CEO.